Who owns KIORA PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Kiora Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Kiora Pharmaceuticals stock

Who bought or sold KIORA PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Alyeska Investment Group 8.3M $5.9M 100% Mar 2024
 View chart
Rosalind Advisors 2.3M $1.6M 100% Mar 2024
 View chart
AIGH Capital Management 2.3M $1.6M 100% Mar 2024
 View chart
Nantahala Capital Management 1.9M $1.3M 100% Mar 2024
 View chart
Velan Capital Investment Management 1.1M $777k 100% Mar 2024
 View chart
ADAR1 Capital Management 1.1M $777k 100% Mar 2024
 View chart
Captrust Financial Advisors 80k $57k 0% Mar 2024
 View chart
Geode Capital Management 37k $26k 0% Mar 2024
 View chart
XTX Topco 25k $18k 111% Mar 2024
 View chart
Vanguard Group 25k $17k 0% Mar 2024
 View chart
Hrt Financial 23k $16k 100% Mar 2024
 View chart
BlackRock 15k $10k 0% Mar 2024
 View chart
Two Sigma Investments 10k $7.3k 100% Mar 2024
 View chart
Virtu Financial 10k $7.0k -64% Mar 2024
 View chart
Tower Research Capital 4.2k $3.0k 0% Mar 2024
 View chart
Goss Wealth Management 200.00 $141.000000 0% Mar 2024
 View chart
Us Bancorp 67.00 $47.000500 0% Mar 2024
 View chart
Wells Fargo & Company 60.00 $42.000000 2% Mar 2024
 View chart
Advisor Group Holdings 36.00 $24.480000 0% Mar 2024
 View chart
Morgan Stanley 8.00 $6.000000 0% Mar 2024
 View chart
FMR 7.00 $5.000100 250% Mar 2024
 View chart
Albion Financial Group 6.00 $4.999800 0% Mar 2024
 View chart
Jpmorgan Chase & Co 4.00 $3.000000 100% Mar 2024
 View chart

Who sold out of Kiora Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Dec 2023 93k $49k
UBS Group Dec 2023 2.2k $1.2k